s6y CAVANAUGH JAMES H 4

CAVANAUGH JAMES H 4, filed Jul 5, 2006: PRIMARY DOCUMENT

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
HEALTHCARE VENTURES VI LP

(Last) (First) (Middle)
HEALTHCARE VENTURES LLC
44 NASSAU STREET

(Street)
PRINCETON NJ 08542

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
REPLIDYNE INC [ RDYN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/03/2006
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/03/2006 C 3,166,863 A $0(1) 3,463,102(2) I(3) and Direct
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Convertible Preferred $0(4) 07/03/2006 C 8,250,300 (4) (4) Common Stock 8,250,300(4) $0(4) 0 I(1) and Direct
Series C Convertible Preferred $0(5) 07/03/2006 C 7,280,001 (5) (5) Common Stock 7,280,001(5) $0(5) 0 I(1) and Direct
1. Name and Address of Reporting Person*
HEALTHCARE VENTURES VI LP

(Last) (First) (Middle)
HEALTHCARE VENTURES LLC
44 NASSAU STREET

(Street)
PRINCETON NJ 08542

(City) (State) (Zip)
1. Name and Address of Reporting Person*
HEALTHCARE PARTNERS VI LP

(Last) (First) (Middle)
HEALTHCARE VENTURES LLC
44 NASSAU STREET

(Street)
PRINCETON NJ 08542

(City) (State) (Zip)
1. Name and Address of Reporting Person*
CAVANAUGH JAMES H

(Last) (First) (Middle)
HEALTHCARE VENTURES LLC
44 NASSAU STREET

(Street)
PRINCETON NJ 08542

(City) (State) (Zip)
1. Name and Address of Reporting Person*
LITTLECHILD JOHN W

(Last) (First) (Middle)
55 CAMBRIDGE PARKWAY
SUITE 301

(Street)
CAMBRIDGE MA 02142

(City) (State) (Zip)
1. Name and Address of Reporting Person*
WERNER HAROLD R

(Last) (First) (Middle)
HEALTHCARE VENTURES LLC
44 NASSAU STREET

(Street)
PRINCETON NJ 08542

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Mirabelli Christopher

(Last) (First) (Middle)
55 CAMBRIDGE PARKWAY
SUITE 301

(Street)
CAMBRIDGE MA 02142

(City) (State) (Zip)
1. Name and Address of Reporting Person*
AGUIAR ERIC

(Last) (First) (Middle)
HEALTHCARE VENTURES LLC
44 NASSAU STREET

(Street)
PRINCETON NJ 08542

(City) (State) (Zip)
1. Name and Address of Reporting Person*
CROUSE WILLIAM W

(Last) (First) (Middle)
HEALTHCARE VENTURES LLC
44 NASSAU STREET

(Street)
PRINCETON NJ 08542

(City) (State) (Zip)
Explanation of Responses:
1. Not Applicable
2. Includes 296,239 shares of the Issuer's common stock issued to HealthCare Ventures VI, L.P. ("HCVVI") in satisfaction of accumulated dividends on the Reporting Person's Series A and Series C Convertible Preferred Stock.
3. These securities are owned by HCVVI. These securities are indirectly beneficially owned by HealthCare Partners VI, L.P. ("HCPVI"), the General Partner of HCVVI, and each of James Cavanaugh, Harold Werner, John Littlechild, Christopher Mirabelli, Augustine Lawlor, William Crouse and Eric Aguiar, the general partners of HCPVI. Drs. Cavanaugh, Mirabelli and Aguiar and Messrs. Werner, Littlechild, Crouse and Lawlor disclaim beneficial ownership of those securities in which they do not have a pecuniary interest and this report shall not be deemed an admission that they are the beneficial owners of these securities for purposes of Section 16 except to the extent of their pecuniary interest therein.
4. These securities automatically converted into 1,682,361 shares of the Issuer's Common Stock on July 3, 2006, the closing of the initial public offering of the Issuer. The conversion of the Series A Convertible Preferred Stock gives effect to the Issuer's 1 for 4.904 reverse stock split.
5. These securities automatically converted into 1,484,502 shares of the Issuer's Common Stock on July 3, 2006, the closing of the initial public offering of the Issuer. The conversion of the Series C Convertible Preferred Stock gives effect to the Issuer's 1 for 4.904 reverse stock split.
Remarks:
/s/Jeffrey Steinberg, Administrative Partner, HealthCare Ventures VI, L.P. 07/03/2006
/s/Jeffrey Steinberg, Administrative Partner for HealthCare Partners VI, L.P. 07/03/2006
/s/Jeffrey Steinberg, Attorney-in-Fact for James H. Cavanaugh 07/03/2006
/s/Jeffrey Steinberg, Attorney-in-Fact for John Littlechild 07/03/2006
/s/Jeffrey Steinberg, Attorney-in-Fact for Harold Werner 07/03/2006
/s/Jeffrey Steinberg, Attorney-in-Fact for Christopher Mirabelli 07/03/2006
/s/Jeffrey Steinberg, Attorney-in-Fact for Eric Aguiar 07/03/2006
/s/Jeffrey Steinberg, Attorney-in-Fact for William Crouse 07/03/2006
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.